Matches in Nanopublications for { ?s ?p "[Furthermore, CD24 may contribute to resistance to HER2-targeted therapy and, therefore, is itself a potential therapeutic target in HER2-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1175613.RAnsZePAkuOCUiDqsgAfEMuX6SYgwSWzFqw22tsfUQ0Do130_assertion description "[Furthermore, CD24 may contribute to resistance to HER2-targeted therapy and, therefore, is itself a potential therapeutic target in HER2-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175613.RAnsZePAkuOCUiDqsgAfEMuX6SYgwSWzFqw22tsfUQ0Do130_provenance.
- NP1175619.RA-2p24gT8kGwxpX95F97VZPQjf4DOL8DeBegP37OQmHw130_assertion description "[Furthermore, CD24 may contribute to resistance to HER2-targeted therapy and, therefore, is itself a potential therapeutic target in HER2-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175619.RA-2p24gT8kGwxpX95F97VZPQjf4DOL8DeBegP37OQmHw130_provenance.